Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, January 05, 2023
AmerisourceBergen Corporation announced the completion of its acquisition of PharmaLex Holding GmbH.
read more
Amgen announced the groundbreaking of its new next-generation biomanufacturing plant that will be constructed at its West Greenwich, R.I. campus.
read more
Amgen has announced plans to build a new state-of-the-art next-generation biomanufacturing plant at its campus in West Greenwich, R.I.
read more
Thursday, January 17, 2013
Amgen today announced plans to build a new manufacturing facility in the Tuas Biomedical Park area of Singapore. Over the next several years, Amgen anticipates investing approximately $200 million to build an innovative new facility, which will ...
read more
Wednesday, December 06, 2017
Carmot and Amgen will work to select therapeutic targets and identify drug candidates.
read more
Wednesday, November 13, 2019
Amneal Pharmaceuticals is voluntarily recalling Ranitidine Tablets, 150 mg and 300 mg, and Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL to the consumer level.
read more
AMPAC Fine Chemicals announced Lee Gauthier has joined AFC's executive team as Vice President of Operations responsible for manufacturing across all AFC's sites.
read more
Albany, NY (April 23, 2013) — AMRI announced today that it has entered into a new five-year service agreement with Ono Pharmaceutical Company, Ltd., (TSE: 4528), a pharmaceutical company headquartered in Osaka, Japan. Under the terms of the agreement...
read more
AMRI, a leading global contract research and manufacturing organization, has announced that the Board of Directors has unanimously voted to separate the role of Chairman and Chief Executive Officer and has named William S. Marth, an active member of ...
read more
AMRI announced today that it has entered into a multi-year supply agreement for an undisclosed product with Shire US Manufacturing Inc., whose parent company, Shire plc, is a global company that focuses its business on behavioral health, gastro ...
read more
AMRI, a leading global contract research and manufacturing organization, announced today the appointment of Ian Shott as President of AMRI Europe, reporting to Thomas D’Ambra, Ph.D., chairman, president and CEO. In this newly created role, Mr. Shott ...
read more
Thursday, September 21, 2017
In response to evolving industry guidelines, AMRI has assembled a medical device solutions team to help customers navigate the regulatory complexities of developing and testing medical device products.
read more
Thursday, October 03, 2013
AMRI today announced that its wholly owned subsidiary, Albany Molecular Research (UK) Ltd., located in Holywell, Wales, United Kingdom, has been awarded a seven-year contract for the development and manufacture of an active ingredient under clinical...
read more
Albany Molecular Research, a contract research development and manufacturing organization, announced that it is changing its name to Curia, effective July 12, 2021. The new name reinforces the company’s strategic positioning as an end-to-end global ...
read more
AMRI announced the company’s manufacturing facility in Rensselaer, NY has been designated “Industry Leader” as part of its re-certification under the SafeBridge® program for "Potent Compound Safety Certification."
read more